Paul V. Maier, Director at International Stem Cell CORP (ISCO.OB), sold 40,000 shares at $1.85 ($74K) on 2011-01-20, disclosed to the SEC on 2011-01-28.
Scheduled sale ($74k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.95 | 10,000 | $20K | 26.4% |
| 2 | $1.89 | 10,000 | $19K | 25.6% |
| 3 | $1.85 | 10,000 | $19K | 25.1% |
| 4 | $1.69 | 10,000 | $17K | 22.9% |
| Total | $1.84 avg | 40,000 | $74K | 100% |
| Filing → |
| ETON | BUY | 2018-11-15 | $30K | — | Filing → |
| MBVX | SELL | 2018-01-24 | $30K | — | Filing → |
| MBVX | BUY | 2015-06-02 | $12K | — | Filing → |